J2271 — Injection, morphine sulfate, 100mg
J2271 is a HCPCS Level II code for injection, morphine sulfate, 100mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2014 and is not valid on new claims.
This code has been terminated
CMS terminated J2271 on December 31, 2014. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Not payable by Medicare
Medicare does not pay this code. It may still be valid for another payer, but a Medicare claim carrying it will not be reimbursed.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J2271
- Long descriptor
- Injection, morphine sulfate, 100mg
- Short descriptor
- Morphine so4 injection 100mg
- Added
- January 1, 1999
- Terminated
- December 31, 2014
- BETOS
- O1E
- Pricing indicator
- 00 — Not priced by Part B
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.
Codes adjacent to J2271
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J2271 is not quite right, the correct code is very often within a few positions of it.
- J2250Injection, midazolam hydrochloride, per 1 mg
- J2251Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
- J2252Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
- J2253Injection, midazolam (seizalam), 1 mg
- J2260Injection, milrinone lactate, 5 mg
- J2265Injection, minocycline hydrochloride, 1 mg
- J2267Injection, mirikizumab-mrkz, 1 mg
- J2270Injection, morphine sulfate, up to 10 mg
- J2272Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg
- J2274Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
- J2275Injection, morphine sulfate (preservative-free sterile solution), per 10 mgterminated
- J2277Injection, motixafortide, 0.25 mg
- J2278Injection, ziconotide, 1 microgram
- J2280Injection, moxifloxacin, 100 mg
- J2281Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg
- J2290Injection, nafcillin sodium, 20 mg
Questions about J2271
What is HCPCS code J2271?
J2271 is a HCPCS Level II code for injection, morphine sulfate, 100mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J2271?
The CMS HCPCS file marks J2271 as "Not payable by Medicare". Medicare does not pay this code. It may still be valid for another payer, but a Medicare claim carrying it will not be reimbursed.
Is J2271 still valid?
No. J2271 was terminated on December 31, 2014 and should not be used on new claims.